Pfizer/Aventis Exubera NDA Delayed Until 2002; FDA May Require More Data

Pfizer/Aventis' Exubera inhaled insulin NDA is not expected to be filed until the second half of 2002 if FDA requires additional data, according to development partner Inhale Therapeutic Systems.